| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Protokinetix, Inc. (PKTX) has 0 insiders with recent SEC Form 4 filings, including 32 buys and 0 sells. PKTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2019 | Smith Clarence Edward | President &CEO | Buy | 500,000 | $0.06 | $30,000.00 | +0.8% | |
| Dec 31, 2018 | Smith Clarence Edward | President &CEO | Buy | 1,833,333 | $0.06 | $109,999.98 | +3.2% | |
| Dec 14, 2018 | Smith Clarence Edward | President &CEO | Buy | 300,773 | $0.08 | $23,345.23 | +0.7% | |
| Sep 17, 2018 | Smith Clarence Edward | President &CEO | Buy | 150,000 | $0.12 | $17,988.13 | +0.6% | |
| Aug 2, 2018 | Guzzetta Michael Richard | CFO | Buy | 29,987 | $0.06 | $1,939.22 | +41.1% | |
| Jun 29, 2018 | Smith Clarence Edward | President &CEO | Buy | 840,760 | $0.05 | $42,038.00 | +1.5% | |
| Jun 22, 2018 | Smith Clarence Edward | President &CEO | Buy | 47,000 | $0.09 | $4,066.40 | +0.5% | |
| Jun 15, 2018 | Smith Clarence Edward | President &CEO | Buy | 448,500 | $0.10 | $43,509.60 | +2.1% | |
| Jun 11, 2018 | Smith Clarence Edward | President &CEO | Buy | 203,700 | $0.08 | $16,859.50 | +1.7% | |
| Jun 5, 2018 | Smith Clarence Edward | President &CEO | Buy | 288,729 | $0.07 | $21,620.53 | +2.6% |